CDKN2D Protein (GST tag)

Produktnummer ABIN6699768

Produktdetails

Target: CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))

Spezies: Human

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses CDKN2D Protein ist gelabelt mit GST tag.

Applikation: Western Blotting (WB)

Kreuzreaktivität: Human

Produktmerkmale: CDKN2D, p19, INK4D, p19-INK4D, Cyclin-dependent kinase 4 inhibitor D, p19-INK4d

Aufreinigung: Recombinant full-length human p19INK4D was expressed in E. coli cells using an N-Terminal Glutathione-S-Transferase fusion protein. The purity was determined to be >90% by densitometry.

Anwendungsinformationen

Applikationshinweise:

Application Note: p18INK4D Protein is stored in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25 % glycerol. p18INK4D Protein is suitable for use in Western Blot and Kinase Assay. Expect a band approximately ~44 kDa on specific lysates or tissues. Specific conditions for reactivity should be optimized by the end user.

Western Blot Dilution: User Optimized

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.2 μg/μL

Lagerung: -80 °C

Informationen zur Lagerung: -80 °c

Haltbarkeit: 12 months

Antigendetails

Target: CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))

Andere Bezeichnung: p19INK4D (CDKN2D Produkte)

Synonyme: ink4d Protein, p19 Protein, p19-ink4d Protein, CDKN2D Protein, ank2 Protein, INK4D Protein, p19-INK4D Protein, INK4d Protein, p19INK4d Protein, cyclin-dependent kinase inhibitor 2D S homeolog Protein, cyclin dependent kinase inhibitor 2D Protein, cyclin-dependent kinase inhibitor 2D Protein, Cyclin-dependent kinase 4 inhibitor D Protein, cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) Protein, similar to cyclin-dependent kinase inhibitor 2D Protein, cdkn2d.S Protein, CDKN2D Protein, cdkn2d Protein, cdn2d Protein, Cdkn2d Protein

Pathways: Zellzyklus, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling